NYSE: CLX
Clorox Co Stock

$167.40+0.43 (+0.26%)
Updated Dec 9, 2024
CLX Price
$167.40
Fair Value Price
N/A
Market Cap
$20.72B
52 Week Low
$127.60
52 Week High
$171.37
P/E
58.13x
P/B
345.35x
P/S
2.7x
PEG
1.52x
Dividend Yield
2.89%
Revenue
$7.47B
Earnings
$357.00M
Gross Margin
44.5%
Operating Margin
8.34%
Profit Margin
4.8%
Debt to Equity
87.88
Operating Cash Flow
$896M
Beta
0.28
Next Earnings
Jan 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A

CLX Overview

The Clorox Company manufactures and sells a variety of consumer staples products, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Clorox products are sold primarily through mass merchandisers, retail outlets, e-commerce channels, distributors, and medical supply providers under the Burt's Bees, Formula 409, Glad, Hidden Valley, Kingsford, Kitchen Bouquet, KC Masterpiece, and other brands. The company was founded in 1913 and is headquartered in Oakland, CA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLX's potential to beat the market

AStrong Buy
  • Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More

Zen Rating Component Grades

C
Value
B
Growth
C
Momentum
C
Sentiment
B
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Household & Personal Product

Industry Rating
B
CLX
Ranked
#1 of 25

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$11.00B
$7.89B
$32.63B
View Top Household & Personal Product Stocks

Be the first to know about important CLX news, forecast changes, insider trades & much more!

CLX News

Overview

Due Diligence Score

Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLX ($167.40) is trading above its intrinsic value of $55.79, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLX is poor value based on its earnings relative to its share price (58.13x), compared to the US market average (29.44x)
P/E vs Market Valuation
CLX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CLX due diligence checks available for Premium users.

Valuation

CLX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
58.13x
Industry
32.84x
Market
29.44x
CLX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CLX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
345.35x
Industry
7.44x
CLX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLX price to earnings growth (PEG)

For valuing profitable companies with growth potential

CLX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CLX's financial health

Profit margin

Revenue
$1.8B
Net Income
$99.0M
Profit Margin
5.6%
CLX's Earnings (EBIT) of $623.00M... subscribe to Premium to read more.
Interest Coverage Financials
CLX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.5B
Liabilities
$5.3B
Debt to equity
87.88
CLX's short-term liabilities ($1.58B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLX's long-term liabilities ($3.69B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$221.0M
Investing
$89.0M
Financing
-$237.0M
CLX's operating cash flow ($896.00M)... subscribe to Premium to read more.
Debt Coverage Financials

CLX vs Household & Personal Product Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLXA$20.72B+0.26%58.13x345.35x
CHDC$25.94B-1.23%46.85x6.19x
ELD$29.32B+2.98%143.30x5.77x
ELFC$7.91B+0.62%72.78x10.87x
HIMSB$7.13B-4.67%69.43x16.20x

Clorox Co Stock FAQ

What is Clorox Co's quote symbol?

(NYSE: CLX) Clorox Co trades on the NYSE under the ticker symbol CLX. Clorox Co stock quotes can also be displayed as NYSE: CLX.

If you're new to stock investing, here's how to buy Clorox Co stock.

What is the 52 week high and low for Clorox Co (NYSE: CLX)?

(NYSE: CLX) Clorox Co's 52-week high was $171.37, and its 52-week low was $127.60. It is currently -2.32% from its 52-week high and 31.19% from its 52-week low.

How much is Clorox Co stock worth today?

(NYSE: CLX) Clorox Co currently has 123,781,318 outstanding shares. With Clorox Co stock trading at $167.40 per share, the total value of Clorox Co stock (market capitalization) is $20.72B.

Clorox Co stock was originally listed at a price of $39.69 in Dec 31, 1997. If you had invested in Clorox Co stock at $39.69, your return over the last 26 years would have been 321.77%, for an annualized return of 5.69% (not including any dividends or dividend reinvestments).

How much is Clorox Co's stock price per share?

(NYSE: CLX) Clorox Co stock price per share is $167.40 today (as of Dec 9, 2024).

What is Clorox Co's Market Cap?

(NYSE: CLX) Clorox Co's market cap is $20.72B, as of Dec 10, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Clorox Co's market cap is calculated by multiplying CLX's current stock price of $167.40 by CLX's total outstanding shares of 123,781,318.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.